Whitsell Innovations, Inc. Offers eCTD Submissions through the FDA Electronic Submission Gateway

Whitsell Innovations (WI), Inc. is pleased to announce that it is offering its clients eCTD submissions through the FDA Electronic Submission Gateway (ESG).  With this added capability, WI can provide regulatory support from the writing of the regulatory documents such as Investigational New Drug Applications (INDs) and Abbreviated New Drug Applications (ANDAs) through their submission in an efficient manner.

[quotes class=”quoteleft”]“We’re excited to add this new functionality,” says WI Founder and President Robin Whitsell. “It allows us to bring a higher level of service to our clients.”[/quotes]